Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-HSCs and ATG in Severe Aplastic Anemia
NCT02407470Phase 2Unknown
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in aplastic anemia (3 arms). Primary endpoint: Engraftment at 42 days post AD-HSC transplantation. Status: unknown.
02
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02407470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407470.